Education
About Us
Working with TipRanks
Follow Us
Senseonics Holdings Inc. (SENS)
:SENS
SENS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.25 - $1.40
Previous CloseN/A
Volume3.00M
Average Volume (3M)5.97M
Market Cap
$377.20M
Enterprise Value$302.00M
Total Cash (Recent Filing)$74.91M
Total Debt (Recent Filing)$61.05M
Price to Earnings (P/E)―
Beta1.67
Next Earnings
Nov 11, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding814,680,900
10 Day Avg. Volume6,731,846
30 Day Avg. Volume5,970,640
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue11.14
Enterprise Value/Gross Profit56.39
Enterprise Value/Ebitda-5.10
Forecast
1Y Price Target
$1.28Price Target Upside128.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
Market AdoptionAn endocrinologist sees an increase in adoption of Eversense 365 among patients, indicating a positive trend for SENS technology.
Product AppealThe Eversense 365 platform addresses top complaints of competitive CGMs and previous sensors from SENS, suggesting potential growth for SENS.
Strategic DevelopmentThe transition to complete commercial control is seen as a strategic win, enabling better management of the Eversense 365 rollout with a more focused sales and investment strategy.
Bears Say
Short-term CostsDespite the higher short-term costs, profitability could become much better in the longer term due to better investment and higher margins.
Transition ChallengesThe company plans to use temporary transition service agreements with Ascensia to commercialize in ex-U.S. territories until an internal commercial network can be built.
Senseonics Holdings News
SENS FAQ
What was Senseonics Holdings Inc.’s price range in the past 12 months?
Senseonics Holdings Inc. lowest stock price was $0.25 and its highest was $1.40 in the past 12 months.
What is Senseonics Holdings Inc.’s market cap?
Senseonics Holdings Inc.’s market cap is $377.20M.
When is Senseonics Holdings Inc.’s upcoming earnings report date?
Senseonics Holdings Inc.’s upcoming earnings report date is Nov 11, 2025 which is in 34 days.
How were Senseonics Holdings Inc.’s earnings last quarter?
Senseonics Holdings Inc. released its earnings results on Aug 06, 2025. The company reported -$0.02 earnings per share for the quarter, the consensus estimate of -$0.02 by $0.
Is Senseonics Holdings Inc. overvalued?
According to Wall Street analysts Senseonics Holdings Inc.’s price is currently Undervalued.
Does Senseonics Holdings Inc. pay dividends?
Senseonics Holdings Inc. does not currently pay dividends.
What is Senseonics Holdings Inc.’s EPS estimate?
Senseonics Holdings Inc.’s EPS estimate is -0.02.
How many shares outstanding does Senseonics Holdings Inc. have?
Senseonics Holdings Inc. has 814,680,900 shares outstanding.
What happened to Senseonics Holdings Inc.’s price movement after its last earnings report?
Senseonics Holdings Inc. reported an EPS of -$0.02 in its last earnings report, expectations of -$0.02. Following the earnings report the stock price went down -6.122%.
Which hedge fund is a major shareholder of Senseonics Holdings Inc.?
Currently, no hedge funds are holding shares in SENS
Senseonics Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.28 (128.57% Upside)
$1.28 (128.57% Upside)
Blogger Sentiment
Bullish
SENS Sentiment 70%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Increased
By 184.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 4.0%
Last 30 Days ▲ 4.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
64.72%
12-Months-Change
Fundamentals
Return on Equity
-102.61%
Trailing 12-Months
Asset Growth
34.70%
Trailing 12-Months
Company Description
Senseonics Holdings Inc.
Senseonics Holdings, Inc. is a medical technology company specializing in the development of innovative glucose monitoring systems for people with diabetes. The company is primarily focused on its flagship product, the Eversense Continuous Glucose Monitoring (CGM) system, which offers real-time glucose monitoring through an implantable sensor that lasts up to 90 days. Senseonics operates in the healthcare sector, specifically within diabetes management, and aims to improve the quality of life for patients by providing more accurate and convenient glucose monitoring solutions.
SENS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in new patient starts and revenue, driven by effective marketing and strategic partnerships. However, challenges remain in terms of financial losses and dependency on payer adjustments. Overall, the positive aspects of growth and strategic positioning seem to outweigh the ongoing financial challenges.View all SENS earnings summariesSENS Stock 12 Month Forecast
Average Price Target
$1.28
▲(128.57% Upside)
Technical Analysis
Ownership Overview
4.39% Insiders
4.83% Mutual Funds
7.96% Other Institutional Investors
78.10% Public Companies and
Individual Investors